Cerebral Blood Flow and PETCO2 on Neuromuscular Function During Environmental Stress
The Influence of Cerebral Blood Flow and Alkalosis on Neuromuscular Function During Environmental Stress
Environmental stress, such as low oxygen availability (hypoxia), has been associated with impaired neuromuscular performance; however, the mechanisms associated with these performance decrements remain unclear. While the majority of research suggests that the observed fatigue is related to the central nervous system, the influence of changes in cerebral blood flow (CBF) and associated changes in cerebral pH (partial pressure of carbon dioxide; PCO2) remains unexamined. In response to hypoxic stress, humans hyperventilate to maintain oxygen consumption, resulting in a hypocapnia mediated decrease in CBF and cerebral alkalosis (decreased PCO2). Previous research suggests that hyperventilation induces changes in neural excitability and synaptic transmission; however, it remains unclear if these changes are related to hypocapnia mediated decrease in CBF or cerebral alkalosis or both.
The purpose of the proposed research program is to examine the influence of changes in CBF and cerebral alkalosis on neuromuscular function during environmental stress. The research program will consist of 2 separate projects, summarized below in a table outlining the proposed protocols and resultant physiological manipulations. During each manipulation, neuromuscular function will be evaluated and compared to baseline (normoxic) conditions using a repeated measures design.
The research program will consist of 2 separate projects. Project 1 will examine the changes in CBF and alkalosis by using (a) indomethacin (decrease CBF; no change PCO2) and (b) hypocapnia (decrease CBF; decrease PCO2). Using a similar experimental design, Project 2 will examine the change in CBF and alkalosis during hypoxia by using (a) poikilocapnic hypoxia (decrease PO2; decrease CBF; decrease PCO2), (b) isocapnic hypoxia (decrease PO2; no change CBF; no change PCO2) and (c) isocapnic hypoxia + indomethacin (decrease PO2; decrease CBF; no change PCO2). During each manipulation, neuromuscular function will be evaluated and compared to baseline (normoxic) conditions using a repeated measures design.
Therefore, Project 1 will examine the separate and combined effect of changes in CBF and cerebral alkalosis on neuromuscular function independent of environmental manipulations. Subsequently, Project 2 will examine neuromuscular function during hypoxia while controlling CBF and cerebral alkalosis. It is hypothesized that changes in PCO2 and therefore, changes in cerebral alkalosis will contribute to neuromuscular fatigue independent of changes in CBF and oxygen availability.
調査の概要
研究の種類
入学 (実際)
段階
- フェーズ 4
連絡先と場所
研究場所
-
-
Ontario
-
St Catharines、Ontario、カナダ、L2S 3A1
- Brock University
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- 18 to 25 yrs old; healthy males
Exclusion Criteria:
- diagnosed medical condition; NSAID allergy; smoker; high altitude exposure; implants
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:基礎科学
- 割り当て:ランダム化
- 介入モデル:単一グループの割り当て
- マスキング:独身
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的:Drug
Indomethacin 1.2 mg kg 1 dose
|
|
|
プラセボコンパレーター:Placebo
flour capsule
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
安静時運動閾値
時間枠:ベースラインからの変化 90分
|
運動誘発電位は、運動皮質の経頭蓋磁気刺激後の筋肉から記録されます。
安静時運動閾値は、運動誘発電位を誘発するために必要な最小刺激強度として定義されます。
安静時運動閾値はミリボルトで定量化されます。
|
ベースラインからの変化 90分
|
|
最大随意収縮
時間枠:ベースラインからの変化 90分
|
最大随意収縮 (MVC) テスト中、参加者の右腕は、前腕の屈曲を分離し、橈側手根屈筋による力の生成を測定するために使用されるカスタムメイドのデバイスに固定されます。
参加者は 5 秒間の MVC を生成するように求められ、収縮の期間を通じて最大の力の生成を維持するように口頭で奨励されます。
MVC は、ニュートン メートルでの最大の力の生成として定量化されます。
|
ベースラインからの変化 90分
|
|
H-Reflex Amplitude
時間枠:Change from baseline 90-minutes
|
The H-Reflex is an indirect measure of motor neuron excitability.
Initially, a maximal M-wave (M-max) will be elicited by stimulating (1 ms in duration; 15 s between stimuli) the median nerve incrementally (2 V increments) until the largest waveform is observed.
The peak-to-peak amplitude of this waveform is considered M-max.
Using similar procedures as above, a sub-maximal M-wave of 5% M-max will be elicited and the amplitude of the resultant H-reflex (a small waveform observed following the submaximal M-wave) will be calculated.
The amplitude of the H-reflex will be quantified in milllivolts.
|
Change from baseline 90-minutes
|
|
H-reflex latency
時間枠:Change from baseline 90-minutes
|
The H-Reflex is an indirect measure of motor neuron excitability.
Initially, a maximal M-wave (M-max) will be elicited by stimulating (1 ms in duration; 15 s between stimuli) the median nerve incrementally (2 V increments) until the largest waveform is observed.
The peak-to-peak amplitude of this waveform is considered M-max.
Using similar procedures as above, a sub-maximal M-wave of 5% M-max will be elicited and the amplitude of the resultant H-reflex (a small waveform observed following the submaximal M-wave) will be calculated.
The onset latency of the H-reflex will be quantified in milliseconds.
|
Change from baseline 90-minutes
|
|
Voluntary Activation
時間枠:Change from baseline 90-minutes
|
The level of neural drive to muscle during contraction is termed voluntary activation and will be estimated by interpolation of a single supramaximal motor evoked potential during the 5-second MVC contraction.
If extra force is evoked by the 'superimposed' stimulus then either the stimulated axons were not all recruited voluntarily or they were discharging at sub-tetanic rates.
Therefore, voluntary activation will be quantified as the amplitude of maximal voluntary force production, relative to the amplitude of the supramaximal MEP.
|
Change from baseline 90-minutes
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
中大脳動脈の血流速度
時間枠:ベースラインからの変化 90分
|
中大脳動脈 (MCA) の血流速度は、2 MHz の経頭蓋ドップラー (TCD) 超音波プローブによって非侵襲的に測定され、快適なヘッドバンドに両側で取り付けられ、耳介の吻側の頬骨弓の前方に固定されます。
ドップラー プローブは、一時的なウィンドウ (耳の近く) でペーシングされ、実験プロトコルの期間中ずっとその場所に残ります。
MCA 速度は cm/s で定量化されます。
|
ベースラインからの変化 90分
|
|
Brachial Artery Blood flow
時間枠:Change from baseline 90-minutes
|
Brachial artery blood flow will be measured non-invasively using a high-resolution ultrasound machine.
Participants will lie supine with their forearm extended in a comfortable position.
Blood flow measurements will be taken in the top 1/3 of the upper arm over the duration of 10 cardiac cycles (approximately 60 seconds).
Blood flow will be quantified in L/min.
|
Change from baseline 90-minutes
|
|
Internal Carotid Artery Blood Flow
時間枠:Change from baseline 90-minutes
|
Internal carotid artery (ICA) blood flow will be measured non-invasively using a high-resolution ultrasound machine.
Participants will lie supine with a slight extension of the neck and at 45° of lateral flexion away from the side being scanned.
ICA measurements will be taken 1 cm superior to the common carotid bifurcation over the duration of 10 cardiac cycles (approximately 60 seconds).
Blood flow will be quantified in L/min.
|
Change from baseline 90-minutes
|
|
Blood pressure
時間枠:Change from baseline 90-minutes
|
Beat by beat blood pressure will be calculated from the blood pressure waveform using finger photoplethysmography (Nexfin, bmeye), with a finger cuff placed directly over the middle finger on the left hand.
Blood pressure will be quantified in mmHg.
|
Change from baseline 90-minutes
|
|
Pulse oximetry
時間枠:Change from baseline 90-minutes
|
A pulse oximetry probe will be placed over a finger to provide a continuous, non-invasive measurement of the blood oxygen saturation to confirm that the end-tidal forcing system is controlling oxygen delivery at the desired levels during each experiment.
Oxygen saturation will be quantified as a percentage.
|
Change from baseline 90-minutes
|
|
Heart Rate
時間枠:Change from baseline 90-minutes
|
Heart rate will be measured by electrocardiogram.
Heart rate will be quantified in beats per minute.
|
Change from baseline 90-minutes
|
|
End-Tidal Gas Concentrations
時間枠:Change from baseline 90-minutes
|
The end-tidal concentrations of oxygen and carbon dioxide will be measured and reported in mmHg.
|
Change from baseline 90-minutes
|
協力者と研究者
スポンサー
捜査官
- 主任研究者:Stephen Cheung, PhD、Brock University
研究記録日
主要日程の研究
研究開始
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (見積もり)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
追加の関連 MeSH 用語
その他の研究ID番号
- 12-167
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。